Call us +91 -7376325889/ 7376335889
Mail
Support
Partners
Careers
Knowledge Center
Downloads
Margin Calculator
Equity
F&O
MF
Online Trading
Open an Account
Back Office
Apply IPO
ABOUT US
SERVICES
MARKETS
Equity
Derivatives
Mutual Fund
IPO
PORTFOLIO
OUR RECOMMENDATIONS
CONTACT US
CALCULATORS
MENU
×
HOME
SERVICES
MARKETS
PORTFOLIO
OUR RECOMMENDATIONS
ABOUT US
SERVICES
CONTACT US
CALCULATORS
Online Trading
Open an Account
Back Office
Apply IPO
Equity Analysis
Company Profile
Price
Volume
Analysis
Company Profile
News Analysis
Corporate Action
Other Markets
Detailed Quotes
Detailed Quotes
Company Snapshot
Company Background
Board of Directors
Profit & Loss
Balance Sheet
Quarterly Results
Key Financial Ratios
Share Holding Pattern
Directors Report
Score Board
MF Holdings
Name Change
Company News
Peer Comparison
Monthly High / Low
Price Chart
Consolidated Quarters
FII Holding
Simple & CAGR Growth
Deliverable Volumes
Profit & Loss
Zydus Lifesciences Ltd
Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value(
)
532321
INE010B01027
177.8674103
NSE Symbol
P/E(TTM)
Mar.Cap(
Cr.)
ZYDUSLIFE
22.79
99189.52
EPS(TTM)
Face Value(
)
Div & Yield %:
43.26
1
0.3
Particulars(INCOME)
Mar 2024
(
Cr)
Mar 2023
(
Cr)
Mar 2022
(
Cr)
Mar 2021
(
Cr)
Mar 2020
(
Cr)
Mar 2019
(
Cr)
Sales Turnover
10818.70
8731.60
7836.90
7780.00
6347.40
6037.40
Excise Duty
0.00
0.00
0.00
0.00
0.00
0.00
Net Sales
10818.70
8731.60
7836.90
7780.00
6347.40
6037.40
Other Income
1084.80
548.40
178.70
89.30
908.70
605.20
Stock Adjustments
131.70
-105.10
46.90
148.30
-15.50
86.00
Total Income
12035.20
9174.90
8062.50
8017.60
7240.60
6728.60
EXPENDITURE :
Raw Materials
3284.60
3066.20
2917.10
2499.70
1936.20
1950.20
Power & Fuel Cost
298.20
278.60
245.20
193.20
208.40
200.20
Employee Cost
1507.50
1321.90
1204.90
1147.30
1077.40
961.20
Other Manufacturing Expenses
347.20
332.50
381.10
363.40
327.30
347.00
Selling & Administrative Expenses
1016.00
1039.80
958.40
1009.10
925.30
755.00
Miscellaneous Expenses
446.80
336.90
578.30
594.40
486.20
280.00
Less : Pre-operative Expenses Capitalised
0.00
0.00
0.00
0.00
0.00
0.00
Total Expenditure
6900.30
6375.90
6285.00
5807.10
4960.80
4493.60
Operating Profit
5134.90
2799.00
1777.50
2210.50
2279.80
2235.00
Interest
390.70
278.20
134.90
70.90
233.90
89.60
Gross Profit
4744.20
2520.80
1642.60
2139.60
2045.90
2145.40
Depreciation
504.40
488.60
478.70
451.10
428.90
358.20
Profit Before Tax
4239.80
2032.20
1163.90
1688.50
1617.00
1787.20
Tax
934.30
461.80
260.20
303.30
164.10
335.40
Fringe Benefit tax
0.00
0.00
0.00
0.00
0.00
0.00
Deferred Tax
-136.00
41.20
45.80
-91.00
40.00
-33.90
Reported Net Profit
3441.50
1529.20
857.90
1476.20
1412.90
1485.70
Extraordinary Items
3.90
-92.27
-237.64
-156.95
-52.67
74.44
Adjusted Net Profit
3437.60
1621.47
1095.54
1633.15
1465.57
1411.26
Adjustment below Net Profit
-54.00
1.80
-6.90
-15.30
-6.00
-294.40
P & L Balance brought forward
10567.40
9289.40
8796.90
7336.00
6645.70
5812.70
Statutory Appropriations
0.00
0.00
0.00
0.00
0.00
0.00
Appropriations
607.30
253.00
358.50
0.00
716.60
358.30
P & L Balance carried down
13347.60
10567.40
9289.40
8796.90
7336.00
6645.70
Dividend
0.00
0.00
0.00
0.00
0.00
0.00
Preference Dividend
0.00
0.00
0.00
0.00
0.00
0.00
Equity Dividend %
300.00
600.00
250.00
350.00
350.00
350.00
Dividend Per Share(Rs)
3.00
6.00
2.50
3.50
3.50
3.50
Earnings Per Share-Unit Curr
34.21
15.11
8.38
14.42
13.80
14.51
Earnings Per Share(Adj)-Unit Curr
34.21
15.11
8.38
14.42
13.80
14.51
Book Value-Unit Curr
156.23
134.78
129.30
124.46
109.96
83.68
Book Value(Adj)-Unit Curr
156.23
134.78
129.30
124.46
109.96
83.68